PharmCADD

About:

PharmCADD uses AI-based protein structure prediction algorithms, MD simulation, and quantum calculation to enable faster drug design.

Website: http://www.pharmcadd.com

Top Investors: Huons, DSC Investment, KDB Capital, KB Securities, KTB Network

Description:

PharmCADD develops a new drug development platform that uses AI-based protein structure prediction algorithms, MD simulation, and quantum calculation to enable faster drug design. PharmCADD's products include Pharmulator, a consolidated drug discovery platform comprised of five core modules such as protein/RNA 3D structure prediction, drug generation, virtual screening, quantum calculation, and toxicity prediction to generate candidates with higher potential; and PharmVAC, a vaccine development platform that provides optimal solutions to users and clients to design, analyze, and visualize more probable RNA sequences for any vaccine candidates.

Total Funding Amount:

$19.8M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Busan, Pusan-jikhalsi, South Korea

Founded Date:

2019-03-05

Founders:

Taehyung Kwon

Number of Employees:

11-50

Last Funding Date:

2021-04-19

IPO Status:

Private

© 2024 MyAiNote.com